Further analysis based on database data showed that the higher expression of DENND1A, the shorter progression-free survival of gastric cancer patients, which indicated that the prognosis of gastric cancer patients with high DENND1A expression is worse (GES26253, n = 190, 242, P = 0.0125) (Figure 7D). Here, DENND1A is linked to gastric cancer.